We believe in innovating with urgency to develop the medicines of tomorrow. Our efforts extend beyond generating our industry-leading #oncology pipeline; our 3,200+ global clinical development team is advancing our investigational medicines with an urgency inspired by the patients we serve worldwide. �� Learn more about our clinical trials at https://bit.ly/4cun16Z.
About us
BeiGene is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter) and Facebook.
- Website
-
http://www.beigene.com
External link for BeiGene
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
- Founded
- 2010
- Specialties
- targeted therapy, immuno-oncology, hematology, oncology, and cancer
Locations
Employees at BeiGene
-
Andrew Harmon
Clinical recruiter at BeiGene
-
Roger Ralph TSCHOPP M.D., M.Sc.
Senior Medical Director, Global Medical Affairs at BeiGene
-
Scott Carter
VP, Associate General Counsel, Business Development at BeiGene
-
Alex Emanuel
Healthcare marketer, commercial operations and analytics professional
Updates
-
We're pleased to welcome Aaron Rosenberg, CFA as Chief Financial Officer, effective July 22. Aaron brings a wealth of expertise and invaluable financial leadership to BeiGene as we responsibly scale our business, look to reinforce our global leadership in #hematology, and build future franchises in other highly prevalent cancers, including lung, breast and gastrointestinal. Learn more: https://bit.ly/3Wb4Ts9
-
-
Congresswoman Bonnie Watson Coleman, a cancer survivor and representative for New Jersey’s 12th Congressional District, recently sat down with Lisa Porat, oncology social worker and our U.S. Lead for Patient Advocacy. Their insightful discussion covered important topics such as honoring cancer survivorship, access to care, finding mental health support and how the Congresswoman’s legislative efforts are shaping cancer care in the U.S. We thank Congresswoman Watson Coleman for her time and ongoing dedication to advancing cancer care. Learn more and watch the full interview here: https://bit.ly/3LqM0MK #CancerCare #PatientAdvocacy #Oncology
-
-
Our flagship U.S. manufacturing and clinical R&D facility is opening next week in Hopewell, N.J.! This state-of-the-art facility will help us scale production of our innovative medicines and portfolio in the future to better serve patients around the world. Read this Axios article to learn more. https://bit.ly/HWRD
-
The opening of our flagship U.S. manufacturing and clinical research and development facility in Hopewell, N.J. later this month is an important part of our efforts to bring our innovative #cancer medicines to more patients. Hear from our Head of Corporate Affairs, Shreya Jani, on what this state-of-the-art facility represents and learn more here: https://lnkd.in/ej7JJ3fy
-
We believe in leading with science to drive innovation. Our dedicated research team is delivering one of the largest and most compelling #oncology pipelines in the industry, uniting cutting-edge science with global development scale to advance tomorrow’s #cancer medicines. Learn more about our approach to cancer biology and areas of innovation at https://bit.ly/3RE0Bs1.
-
We believe in advancing inclusiveness in research and clinical trials and developing innovative treatments that address the unique needs of all patients. We partner with diverse patient communities early in the process and aim to deliver therapies that are safe and effective for more people living with #cancer. Join us in celebrating Disability Pride Month by promoting awareness, fostering inclusivity, and recognizing the significant contributions of individuals with disabilities in our communities. Together, we can create a more equitable future for all. Learn more about our commitment to global health equity at https://lnkd.in/eB6fpQjz. #DisabilityPrideMonth #HealthEquity
-
-
The impact of #cancer extends far beyond the biology of the disease. In recognition of National Minority Mental Health Awareness Month and throughout the year, we advocate for equitable #MentalHealth resources for all, including all cancer patients. Our dedication to global #HealthEquity involves addressing health disparities and bringing awareness to the unique challenges that racial and ethnic minorities face when it comes to mental illness. Learn more about our commitment to making mental health and emotional wellness an integral part of quality cancer care for all patients, their families and care partners at https://bit.ly/3VS5H6r. #TalkAboutIt #NationalMinorityMentalHealthAwarenessMonth
-
-
By 2030, ~14% of the population in Southeast Asia will be 60 or older, rising to 20% by 2050. This aging trend is expected to lead to an increase in chronic diseases, including #cancer, and a greater demand for long-term care. However, health systems in the region are often ill-equipped to manage these challenges, which disproportionately affects disadvantaged vulnerable populations and worsen health inequities. While innovations in medicines are critical, so are the advances in educating and training the #healthcare workforce, which can directly improve access and equity in care. The latest Asia Society report, supported by BeiGene, uses Thailand as a case study to demonstrate the importance of healthcare workforce education in improving cancer control across the region. Read the full report here: https://bit.ly/3RR9MVP.
In 2019, noncommunicable diseases accounted for approximately 40 million deaths — mostly in low-and-middle-income countries — with that number expected to surpass 100 million deaths per year by 2025. With an aging population, Southeast Asia will see an increase in the prevalence of chronic diseases, including cancer, and an increased demand for long-term care to address them. In a new Asia Society Policy Institute report, Alexandra Zenoff, MPH argues that investing in primary health care systems is crucial for improving health equity in Southeast Asia, where many rural populations don’t have access to specialized treatments like cancer care. Featuring Thailand as a case study, the report explores how innovations in health care workforce training could expand and improve equitable access to cancer care. Thanks to BeiGene for its support of this important initiative. #cancer #healthequity #southeastasia https://lnkd.in/dbpqX3Ax